IMPACT OF STATIN INTOLERANCE RATES ON NEED FOR EZETIMIBE AND/OR PCSK9 INHIBITORS FOR MEETING LOW-DENSITY LIPOPROTEIN GOALS IN A REAL-WORLD COHORT WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

Methods: ASCVD patients in the MarketScan database (2012-2013) were sampled with replacement (bootstrapping) and entered into a simulation model which applied the following treatment intensification algorithm in those with low-density lipoprotein cholesterol (LDL-C) >70 mg/dL.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.1663-1663
Main Authors: Cannon, Christopher P, Khan, Irfan, Klimchak, Alexa, Sanchez, Robert, Sasiela, William, Reynolds, Matthew
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Cardiovascular disease
Internal Medicine
Low density lipoprotein
Statins
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods: ASCVD patients in the MarketScan database (2012-2013) were sampled with replacement (bootstrapping) and entered into a simulation model which applied the following treatment intensification algorithm in those with low-density lipoprotein cholesterol (LDL-C) >70 mg/dL.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)35052-0